Chemotherapeutic drug susceptibility associated SNPs are enriched in expression quantitative trait loci

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 20, 2010, Pages 9287-9292

  Gamazon, Eric R ^a   Huang, R Stephanie ^a   Cox, Nancy J ^a   Dolan, M Eileen ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Genome wide association study; Pharmacogenomics

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CARBOPLATIN; CISPLATIN; CYTARABINE; DAUNORUBICIN; ETOPOSIDE;

3' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG RESISTANCE; DRUG SENSITIVITY; FRAMESHIFT MUTATION; GENE EXPRESSION; GENE FREQUENCY; MISSENSE MUTATION; NONSENSE MUTATION; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTINEOPLASTIC AGENTS; DRUG TOXICITY; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INHIBITORY CONCENTRATION 50; LINKAGE DISEQUILIBRIUM; PHARMACOGENETICS; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI;

EID: 77952697081     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1001827107     Document Type: Article

References (33)

1. Welsh MM, et al. (2009) Pharmacogenomic discovery using cell-based models. Pharmacol Rev 61:413-429.
2. Goetz MP, Kamal A, Ames MM (2008) Tamoxifen pharmacogenomics: The role of CYP2D6 as a predictor of drug response. Clin Pharmacol Ther 83:160-166.
3. Hoskins JM, Goldberg RM, Qu P, Ibrahim JG, McLeod HL (2007) UGT1A1*28 genotype and irinotecan-induced neutropenia: Dose matters. J Natl Cancer Inst 99:1290-1295. (Pubitemid 47394168)
4. Daly AK, et al., DILIGEN Study International SAE Consortium (2009) HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet 41:816-819.
5. Link E, et al., SEARCH Collaborative Group (2008) SLCO1B1 variants and statin-induced myopathy - a genomewide study. N Engl J Med 359:789-799.
6. Takeuchi F, et al. (2009) A genome-wide association study confirms VKORC1, CYP2C9, and CYP4F2 as principal genetic determinants of warfarin dose. PLoS Genet 5:e1000433.
7. Hartford CM, et al. (2009) Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity. Blood 113:2145-2153.
8. Huang RS, et al. (2007) A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity. Proc Natl Acad Sci USA 104:9758-9763. (Pubitemid 47175340)
9. Huang RS, et al. (2007) Identification of genetic variants contributing to cisplatin-induced cytotoxicity by use of a genomewide approach. Am J Hum Genet 81:427-437.
10. Li L, et al. (2009) Gemcitabine and arabinosylcytosin pharmacogenomics: Genome-wide association and drug response biomarkers. PLoS ONE 4:e7765.
11. Watters JW, Kraja A, Meucci MA, Province MA, McLeod HL (2004) Genome-wide discovery of loci influencing chemotherapy cytotoxicity. Proc Natl Acad Sci USA 101: 11809-11814. (Pubitemid 39095376)
12. International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437:1299-1320.
13. Hindorff LA, et al. (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106: 9362-9367.
14. Duan S, et al. (2008) Genetic architecture of transcript-level variation in humans. Am J Hum Genet 82:1101-1113.
15. Morley M, et al. (2004) Genetic analysis of genome-wide variation in human gene expression. Nature 430:743-747. (Pubitemid 39071339)
16. Zhang W, et al. (2008) Evaluation of genetic variation contributing to differences in gene expression between populations. Am J Hum Genet 82:631-640.
17. Stranger BE, et al. (2005) Genome-wide associations of gene expression variation in humans. PLoS Genet 1:e78.
18. Huang RS, Duan S, Kistner EO, Hartford CM, Dolan ME (2008) Genetic variants associated with carboplatin-induced cytotoxicity in cell lines derived from Africans. Mol Cancer Ther 7:3038-3046.
19. Huang RS, et al. (2008) Genetic variants contributing to daunorubicin-induced cytotoxicity. Cancer Res 68:3161-3168.
20. Sherry ST, et al. (2001) dbSNP: The NCBI database of genetic variation. Nucleic Acids Res 29:308-311.
21. He L, Hannon GJ (2004) MicroRNAs: Small RNAs with a big role in gene regulation. Nat Rev Genet 5:522-531. (Pubitemid 38868508)
22. Cheung VG, et al. (2003) Natural variation in human gene expression assessed in lymphoblastoid cells. Nat Genet 33:422-425. (Pubitemid 36278862)
23. Sarasquete ME, et al. (2008) Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: A genome-wide single nucleotide polymorphism analysis. Blood 112:2709-2712.
24. Nicolae DL, et al. (2010) Trait-associated SNPs are more likely to be eQTLs: Annotation to enhance discovery from GWAS. PLoS Genet 6:e1000888.
25. Venter JC, et al. (2001) The sequence of the human genome. Science 291:1304-1351.
26. Dickson SP, Wang K, Krantz I, Hakonarson H, Goldstein DB (2010) Rare variants create synthetic genome-wide associations. PLoS Biol 8:e1000294.
27. Cantor RM, Lange K, Sinsheimer JS (2010) Prioritizing GWAS results: A review of statistical methods and recommendations for their application. Am J Hum Genet 86: 6-22.
28. Gamazon ER, et al. (2010) PACdb: A database for cell-based pharmacogenomics. Pharmacogenet Genomics 20:269-273.
29. Abecasis GR, Cardon LR, Cookson WO (2000) A general test of association for quantitative traits in nuclear families. Am J Hum Genet 66:279-292.
30. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100:9440-9445.
31. Alberts R, et al. (2007) Sequence polymorphisms cause many false cis eQTLs. PLoS ONE 2:e622. (Pubitemid 351279929)
32. Gamazon ER, et al. (2010) SCAN: SNP and copy number annotation. Bioinformatics 26: 259-262.
33. Purcell S, et al. (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575. (Pubitemid 47330214)